Pharmaceutical Technology

DECEMBER 12, 2022

Gilead company Kite has entered an international strategic partnership with Arcellx for the joint development and commercialisation of the latter’s T-cell therapy, CART-ddBCMA, to treat relapsed or refractory multiple myeloma patients. Additionally, Kite will make other potential payments to Arcellx.

Development 264

Development Gene Therapy Clinical Trials Clinical Trials 264

Medical Xpress

MAY 16, 2023

A vegan diet does not affect maternal breastmilk concentrations of vitamin B2 and carnitine, nutrients essential for the developing infant. These are the results of an Amsterdam UMC study, presented today at the 55th Annual Meeting of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).

Containment 98

Containment Development 98

Pharmaceutical Technology

OCTOBER 6, 2022

from the US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) to develop a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). Leveraging its outer membrane vesicles (OMV) platform technology, Intravacc will develop the vaccine.

Vaccination 147

Vaccination Vaccine Development Bacterium 147

BioTech 365

JULY 20, 2021

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs In Development, 2021 Research Report – ResearchAndMarkets.com Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs In Development, 2021 Research Report – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Bromodomain Containing Protein 4 (Protein (..)

Protein 40

Protein Containment Development Research 40

BioSpace

MAY 11, 2021

Nearly 50 infants with "bubble baby" disease developed a working immune system after they received a gene therapy that contained the AIDS virus, according to a new study.

Gene Therapy 75

Gene Therapy Containment Gene Development 75

Camargo

OCTOBER 14, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Continued development of the use of complex innovative trial designs. Continue development of the use of Real-World Evidence. Orientation.

Development 189

Development Packaging Packaging Generic Drugs 189

BioTech 365

NOVEMBER 30, 2020

Lygos and High Beauty Sign Agreement to Co-Develop and Commercialize Cosmetic Products Containing Rare Cannabinoids Lygos and High Beauty Sign Agreement to Co-Develop and Commercialize Cosmetic Products Containing Rare Cannabinoids Co-branded High & Bye Refining Oil and Clearing Gel to … Continue reading →

Cosmetics 52

Cosmetics Containment Production Development 52

Camargo

NOVEMBER 15, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The guidance also contains some useful information, despite the limitations described above. That potential has now been realized.

Development 187

Development Manufacturing Production Packaging 187

The Pharma Data

NOVEMBER 30, 2020

30, 2020 – Nearly 15% of talc-based cosmetic products analyzed in a recent study contained asbestos. The voluntary testing method developed by industry is not sensitive enough to screen for asbestos when compared to electron microscopy, the group said. MONDAY, Nov. Food and Drug Administration does not require testing talc supplies.

Containment 52

Containment Production Cosmetics Contamination 52

Pharma Marketing Network

JULY 13, 2023

Your website is your online storefront, so it’s important to choose the best web development company to create it. In the pharmaceutical industry, where trust and credibility are essential, it’s especially important to choose a web development company that understands the specific needs of your business. Trust your gut.

Development 97

Development Regulation Compliance Containment 97

XTalks

APRIL 25, 2024

Now we recognize that over the last ten years or so there have been major developments in pharmacotherapy for the management of different etiologies of heart failure,” says Dr. Nicholas Alp, MD, PhD, FACC, FRCP, Vice President of the Medical Department at Medpace. The Carillon device, developed by Cardiac Dimensions Inc.

Development 111

Development Trials Clinical Trials Clinical Trials 111

Camargo

NOVEMBER 11, 2020

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Still, navigating such patent issues during drug development can be difficult, and Camargo can assist in finding a safe course. Ken Phelps.

Development 242

Development Bioequivalency Generic Drugs Production 242

Scienmag

SEPTEMBER 7, 2021

A research group in Japan has successfully developed a “nanoporous super multi-element catalyst” (1) that contains 14 elements (2) which are mixed uniformly at the atomic level and used as a catalyst.

Containment 40

Containment Development Research 40

BioTech 365

SEPTEMBER 8, 2020

OTCQB: PMCB), a clinical-stage biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that it has successfully completed the second Container Closure Integrity … Continue reading →

Containment 52

Containment Development 52

Camargo

JUNE 4, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: May 2021 Regulatory and Development Updates. In the News: April 2021 Regulatory and Development Updates.

Development 130

Development Production Drugs Marketing 130

Sciensano

APRIL 18, 2023

In order to reduce the amount of packaging waste, the zero-waste trend (bying food in bulk) has recently developed. It is characterisez by the purchase, transport and storage of food using its own containers. But is this trend safe?

Containment 52

Containment Packaging Packaging Contamination 52

Camargo

DECEMBER 13, 2021

The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available. Regulatory Considerations for Biologics. Section 351(a) is the traditional pathway for approving biologics under the PHS Act.

Development 161

Development Production Immune Response Licensing 161

Bio Pharma Dive

MARCH 20, 2023

Speeding up the drug development process through a less optimized containment and delivery system may have been an option in the past, but both expectations and the competitive environment are changing.

Production 130

Production Containment Development Drugs 130

Medical Xpress

FEBRUARY 15, 2023

Human sweat contains chemical information including blood metabolites, ion concentrations, and nutrients. Monitoring this information using a wearable sensor can allow non-invasive (i.e., without blood sampling), real time health status tracking.

Containment 105

Containment Development 105

BioSpace

SEPTEMBER 24, 2020

Even when a first vaccine is finally approved, much of the developing world currently stands to be left behind, as it was during the 2009 H1N1 pandemic.

Containment 62

Containment Vaccination Vaccine Development 62

Medical Xpress

DECEMBER 27, 2022

For Cold Spring Harbor Laboratory (CSHL) Research Professor Alexander Krasnitz, the answers may lie deep within vast databases and hospital archives containing hundreds of thousands of tumor samples. How can we trace cancer's ancestral roots to modern-day solutions?

Research 75

Research Development Containment 75

Scienmag

NOVEMBER 3, 2020

Credit: RUDN University A team of chemists from RUDN University synthesized new organosilicon compounds containing terbium and europium ions. These complexes have an unusual cage-like crystal structure that contains four metal ions.

Containment 105

Containment Development 105

Pharmaceutical Technology

SEPTEMBER 15, 2022

Research by GlobalData (Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition) shows that containment facilities are in high demand as the use of cytotoxic drugs continues to grow. Adding to these factors is that oncology accounts for the majority of marketed, contained drugs. Containment challenges.

Containment 130

Containment Manufacturing Production Contract Manufacturing 130

Scienmag

JUNE 20, 2022

Aiming to produce environmentally friendly alternatives to plastic food wrap and containers, a Rutgers scientist has developed a biodegradable, plant-based coating that can be sprayed on foods, guarding against pathogenic and spoilage microorganisms and transportation damage.

Scientist 58

Scientist Development Packaging Packaging 58

Pfizer

AUGUST 3, 2022

Pfizer to Discontinue Development Program for PF-07265803 for LMNA-Related Dilated Cardiomyopathy. Pfizer to Discontinue Development Program for PF-07265803 for LMNA-Related Dilated Cardiomyopathy. Based on these results, the Phase 3 trial and further development of PF-07265803 will be discontinued. deliesschef.

Development 101

Development Vaccination Vaccine Production 101

Drug Discovery World

DECEMBER 6, 2022

As a result of clear US Food and Drug Administration (FDA) guidelines, the leading vaccine development programmes for Covid-19 were all remarkably similar. At times, this proved a major roadblock during Covid-19, where similar datasets contained unexplained differences and inconsistencies. Pre-specification of effect size .

Development 98

Development Drugs Vaccination Vaccine 98

Scienmag

MAY 28, 2021

Genetics toolkit targets less researched Culex mosquitoes, which transmit West Nile virus and avian malaria Credit: Gantz Lab, UC San Diego Since the onset of the CRISPR genetic editing revolution, scientists have been working to leverage the technology in the development of gene drives that target pathogen-spreading mosquitoes such as Anopheles and (..)

Containment 69

Containment Genetics Research Gene 69

Drug Discovery World

NOVEMBER 29, 2022

The technology can contribute to the development and production of vaccines and drugs for severe diseases much faster and at lower cost. . Now we have succeeded in designing our own DNA that contains the exact instructions to control the quantity of a specific protein,” said Aleksej Zelezniak. . The next step is to use human cells.

DNA 52

DNA Development Research Drugs 52

Pharmaceutical Technology

MAY 10, 2023

This marks a significant development in a tumultuous dispute between the pharmaceutical company and the US government. This research dates to the mid-2000s when CDC scientists developed the PrEP regimen, argued the government. While both Descovy and Truvada contain emtricitabine, they feature different forms of the antiviral tenofovir.

FDA Approval 264

FDA Approval Drugs Containment Licensing 264

Drug Discovery World

MARCH 28, 2023

SolasCure’s first investigational product, Aurase Wound Gel, a hydrogel containing an enzyme cloned from medical maggots which aims to accelerate wound debridement, is due to enter further Phase II efficacy-supporting trials. funding to develop Aurase Wound Gel appeared first on Drug Discovery World (DDW).

Development 52

Development Production Clinical Trials Clinical Trials 52

Scienmag

SEPTEMBER 27, 2021

28, 2021) – The microbiota in the nose and upper throat likely contains biomarkers for assessing how sick an individual infected with SARS-CoV-2 may get and for developing new treatment strategies to improve their outcome, researchers say. AUGUSTA, Ga. Credit: Michael Holahan, Augusta University AUGUSTA, Ga.

Development 52

Development Containment Research Medicine 52

XTalks

JULY 15, 2021

University of Newcastle researchers in Australia have developed a saliva test to evaluate glucose levels in diabetic patients. The test involves the use of testing strips that contain a glucose biosensor with electronic elements in the test’s transistor, like inks, that allow for mass printing of the test strips at low cost.

Development 98

Development Research Containment Manufacturing 98

Drug Discovery World

NOVEMBER 9, 2022

However, there is an increasing need to predict metabolism for other enzymes, such as human Aldehyde Oxidates (AOs), Flavin-containing Monooxygenases (FMOs), and Uridine 5’-diphosphoglucuronosyltransferases (UGTs). . The post AI development duo to advance drug-metabolising enzymes appeared first on Drug Discovery World (DDW).

Development 52

Development Drugs Scientist Containment 52

Drug Discovery World

OCTOBER 19, 2022

Yapan Bio has expanded its capabilities with a new process development facility at Genome Valley, Hyderabad, India, which has enhanced its ability to support end-to-end development and manufacturing of RNA, DNA and gene therapy products starting from plasmids. .

Development 52

Development Gene Therapy RNA DNA 52

Drug Discovery World

NOVEMBER 4, 2022

New research has furthered our understanding of the immune-related factors that drive infection and disease, which will be necessary for an effective tuberculosis (TB) vaccine to be developed. Instead, infection is either eliminated or contained by the infected individual. Most individuals infected with M.tb

Vaccination 52

Vaccination Vaccine Development Bacteria 52

Pharma Times

MARCH 27, 2023

Company is developing a therapy containing an enzyme cloned from medical maggots

Containment 122

Containment Development 122

Camargo

DECEMBER 9, 2020

Camargo can help you to develop the right pricing and access strategy for your product; contact us for more information. A lesser-known provision also grants the same seven-year market exclusivity if the sponsor demonstrates that it does not expect to recover the development costs from selling the drug. Ken Phelps. Bill Stoltman, JD.

Development 140

Development Production Drugs FDA Approval 140